FDA: Irbesartan lots recalled over likely carcinogen
Saturday, January 19, 2019 - 16:50
in Health & Medicine
A drug company has recalled more irbesartan blood pressure medication after discovering a potential human carcinogen.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via